This paper is in the following e-collection/theme issue:

Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1299) JMIR Theme Issue: COVID-19 Special Issue (2002)

Published on in Vol 6 , No 3 (2020) :Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/19538, first published .
Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir

Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir

Statistical Issues and Lessons Learned From COVID-19 Clinical Trials With Lopinavir-Ritonavir and Remdesivir

Authors of this article:

Guosheng Yin 1 Author Orcid Image ;   Chenyang Zhang 1 Author Orcid Image ;   Huaqing Jin 1 Author Orcid Image
Article Authors Cited by Tweetations (1) Metrics
Guosheng Yin 1 , PhD ;   Chenyang Zhang 1 , MSc ;   Huaqing Jin 1 , BSc

1 Department of Statistics and Actuarial Science , The University of Hong Kong , Hong Kong , HK

Corresponding Author:

  • Guosheng Yin, PhD
  • Department of Statistics and Actuarial Science
  • The University of Hong Kong
  • Run Run Shaw Building
  • Pokfulam Road
  • Hong Kong
  • HK
  • Phone: 852 39178313
  • Email: gyin@hku.hk